Skip to main content

Advertisement

Table 5 Complications in Routine F/U and Home F/U patients according to randomization group

From: Attrition in longitudinal randomized controlled trials: home visits make a difference

  ROUTINE F/U, N=187 HOME F/U, N=61
EVENT All % (n) Low MAP N=97, % (n) High MAP N=90 % (n) All % (n) Low MAP N=27, % (n) High MAP N=34, % (n)
Perioperative cardiac and neurologic morbidity and mortality 6.4 (12) 9.3 (9) 3.3 (3) 8.2 (5) 14.8 (4) 2.9 (1)
6-month cardiac and neurologic morbidity and mortality 2.7 (5) 3.1 (3) 2.2 (2) 4.9 (3) 3.7 (1) 5.9 (2)
Total cardiac and neurologic morbidity and mortality 8.6 (16) 12.4 (12) 4.4 (4) 9.8 (6) 14.8 (4) 5.9 (2)
Functional decline (6 months) 7.5 (12) 9.4 (8) 5.3 (4) 7.0 (4) 4.2 (1) 9.1 (3)
Neurocognitive dysfunction (6 months) 12.7 (21) 11.6 (10) 13.8 (11) 10.2 (6) 14.8 (4) 6.3 (2)
Total Combined Outcome 24.0 (45) 28.9 (28) 18.9 (17) 14.8 (9) 22.2 (6) 8.8 (3)
  1. Complications were cardiac morbidity (myocardial infarction, pulmonary edema, adult respiratory distress syndrome and cardiogenic shock); neurologic morbidity (major focal deficit); all-cause mortality; functional decline (>5 point decline in physical component summary measure of the SF-36); and neurocognitive deterioration (within-patient differences on an 11 test neurocognitive battery).